World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
57788
World Ranking
2713
National Ranking
238

Manu Shankar‐Hari publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Manu Shankar‐Hari sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 224 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Manu Shankar‐Hari D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Manu Shankar‐Hari sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

    Mervyn Singer;Clifford S. Deutschman;Christopher Warren Seymour;Manu Shankar-Hari

  • Genetic mechanisms of critical illness in Covid-19.

    E. Pairo-Castineira;E. Pairo-Castineira;S. Clohisey;L. Klaric;A. D. Bretherick

  • Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.

    Jeffrey Seow;Carl Graham;Blair Merrick;Sam Acors

  • Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

    Unknown

  • A dynamic COVID-19 immune signature includes associations with poor prognosis.

    Adam G. Laing;Anna Lorenc;Irene del Molino del Barrio;Irene del Molino del Barrio;Abhishek Das;Abhishek Das

  • The immunology of sepsis

    Tom van der Poll;Manu Shankar-Hari;Manu Shankar-Hari;W. Joost Wiersinga

  • The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity.

    Marcin F. Osuchowski;Martin S. Winkler;Tomasz Skirecki;Sara Cajander

  • A guide to immunotherapy for COVID-19

    Unknown

  • Whole-genome sequencing reveals host factors underlying critical COVID-19

    Unknown

  • Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.

    Michael J. Carter;Michael J. Carter;Matthew Fish;Matthew Fish;Aislinn Jennings;Aislinn Jennings;Katie J. Doores

  • Current gaps in sepsis immunology: new opportunities for translational research.

    Ignacio Rubio;Marcin F Osuchowski;Manu Shankar-Hari;Manu Shankar-Hari;Tomasz Skirecki

  • Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex

    Unknown

  • Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study

    Unknown

  • SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.

    Clemens Gutmann;Kaloyan Takov;Sean A Burnap;Bhawana Singh

  • Sepsis Subclasses: A Framework for Development and Interpretation.

    Kimberley M DeMerle;Derek C Angus;J Kenneth Baillie;Emily Brant

  • Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

    Tobias Welte;R. Phillip Dellinger;Henning Ebelt;Miguel Ferrer

  • Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.

    Carl Graham;Jeffrey Seow;Isabella Huettner;Hataf Khan

  • Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective

    Manu Shankar-Hari;Manu Shankar-Hari;Jo Spencer;William A Sewell;Kathryn M Rowan

  • Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study

    Andrew Conway Morris;Andrew Conway Morris;Deepankar Datta;Manu Shankar-Hari;Jacqueline Stephen

  • Activation-Associated Accelerated Apoptosis of Memory B Cells in Critically Ill Patients With Sepsis.

    Manu Shankar-Hari;David Fear;Paul Lavender;Tracey Mare

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles